LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Verdezyne, Inc., a synthetic biology company focused on the industrial biotechnology markets, today announced it has signed a new project with Genencor, a division of Danisco A/S, a leading industrial biotechnology company that develops and markets innovative enzymes and bio-based products. Under the terms of the arrangement, Verdezyne will utilize its suite of technologies to generate enzyme variants.
